Nvidia buys unpriced French stakes, funds UK compute
Nvidia took undisclosed minority stakes in four French firms and pledged $250M of UK compute. Prior rounds remain the only marks.
Nvidia's minority stakes in Doctolib, Pigment, Genesis AI and Entalpic carry no disclosed size, valuation or ownership, so they set no new price marks. Tech.eu separately reports a $250M UK compute donation for safety research. For founders, each company's last disclosed round remains the only usable benchmark.
Traction Desk · 3 min read- Nvidia took minority stakes in Doctolib, Genesis AI, Pigment and Entalpic; neither Nvidia nor the startups disclosed amounts or percentages, per Trending Topics.
- Tech.eu reports a $250M compute donation over five years for UK agentic safety and security research, including SOFAIR at UCL, BOLD at the University of Oxford and Imperial College London.
- The last disclosed marks are Doctolib at €5.8 billion (2022), Pigment's $145 million Series D (2024), Genesis AI's $105 million seed (2025) and Entalpic's €8.5 million seed (2024).
- Bloomberg reported summer 2026 talks for Genesis AI to raise about $500 million at roughly a $3 billion valuation; this is reported, not confirmed.
- Compute pledged to university labs is not venture capital and should not be read as a funding benchmark.
Nvidia has taken minority stakes in four French companies (Doctolib, Genesis AI, Pigment and Entalpic) and, per Tech.eu, donated $250M of compute over five years to UK AI safety research. Trending Topics dates the French announcement to 13 October 2026. No cheque size, valuation or ownership percentage has been disclosed. The desk's read: this is ecosystem positioning by the dominant compute supplier, and the numbers that matter are the rounds each company already printed.
What is known about the French stakes
Trending Topics reports that neither Nvidia nor the startups disclosed investment sizes or stake percentages, and that Les Echos describes the positions as minority stakes. The deals were announced at a Paris reception, with details in a blog post. Tech.eu quotes Genesis AI as saying: "We are excited that Nvidia is a strategic investor in Genesis AI." Beyond names and direction, there is no price per share, no round size and no disclosed lead investor.
The last disclosed marks for each company
Trending Topics lists the prior data points. Doctolib was valued at €5.8 billion in a 2022 round. Pigment raised a $145 million Series D in 2024, and Entalpic an €8.5 million seed the same year. Genesis AI raised a $105 million seed in 2025, and Bloomberg reported summer 2026 talks on roughly $500 million at about a $3 billion valuation; that is reported, not confirmed. Nvidia's stakes add no verified new mark to any of them.
The UK commitment is compute, not capital
Tech.eu reports a $250M compute donation over five years for UK agentic safety and security research, with part supporting SOFAIR at UCL, BOLD at the University of Oxford and Imperial College London. The recipients are university labs, not startups, so the pledge is compute value rather than cash and is not a venture benchmark. How the figure is valued, and how much each lab receives, was not stated in the reporting reviewed.
Strategic capital and the circularity question
Trending Topics quotes Jensen Huang in Paris saying "Europe needs to get in the race." Asked about criticism that such investing is circular, with Nvidia funding AI companies that then buy its chips, he answered: "In A.I., compute is revenue." The same report says Nvidia has committed nearly $10 billion to Europe's tech ecosystem, including $8 billion over the past year, and plans a further $2 billion in European deals within a week. That further sum is a stated plan, not an announced deal.
Verdict
Treat this as a supplier buying proximity, not a priced venture round. A strategic holder whose chips portfolio companies need is not a financial lead pricing risk. Until stake sizes, valuations or compute-purchase terms surface, founders benchmarking against these four should keep using each company's last disclosed round, and treat the Genesis AI talks as unconfirmed. The UK donation belongs in the research-funding column, not the venture one.
- Which French companies did Nvidia invest in?
- Doctolib, Genesis AI, Pigment and Entalpic. Trending Topics reports that neither Nvidia nor the startups disclosed amounts or percentages, and that Les Echos describes the stakes as minority positions.
- What is the UK compute donation?
- Tech.eu reports $250M of compute over five years for UK agentic safety and security research, with part going to SOFAIR at UCL, BOLD at the University of Oxford and Imperial College London. The recipients are research labs, not startups.
- Do the French stakes reset valuations?
- Not on published evidence. No round size, valuation or ownership split has been disclosed, so each company's last disclosed round remains the reference point.